Mitotech Granted Orphan Drug Designation by FDA for
The US Orphan Drug Designation would provide seven-year market exclusivity if Visomitin was approved for use in LHON....
Source: globenewswire.com
Stay updated with breaking news from Mitotech Sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Orphan Drug Designation would provide seven-year market exclusivity if Visomitin was approved for use in LHON....